COMPANY SUMMARY
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
Financial Summary
| Share Statistics |
SBC |
Industry Median |
Percentile (All Stocks) |
| Market Cap (Mil) |
$314.2 |
$1,742.7 |
32% |
|
| Shares Out (Mil) |
102.6 |
76.7 |
63% |
|
| Institutional Ownership |
1.8% |
89.7% |
3% |
|
| Float (Mil) |
18.1 |
49.4 |
27% |
|
| Beta |
0.59 |
0.82 |
34% |
|
| Avg Daily Volume (000s) |
70 |
521 |
32% |
|
Price Change (52-week) |
(30.4%) |
78.7% |
24% |
|
| Growth |
SBC |
Industry Median |
Percentile (All Stocks) |
| Sales (5yr) |
na |
11.0% |
na |
|
| Net Income (5yr) |
na |
(0.7%) |
na |
|
| EPS (5yr) |
na |
3.1% |
na |
|
| Dividends (5yr) |
na |
0.0% |
0% |
|
| Cash Flow (5yr) |
na |
(18.0%) |
na |
|
| Estimates |
Qtrly |
Current Fiscal Year |
Next Fiscal Year |
| # of Estimates |
4 |
4 |
2 |
| Current EPS |
$0.118 |
$0.465 |
$0.485 |
| Month Ago EPS |
$0.118 |
$0.465 |
$0.485 |
| # Rev Up |
0 |
0 |
0 |
| # Rev Down |
0 |
0 |
1 |
| Three Months Ago EPS |
$0.118 |
$0.458 |
$0.500 |
| Year/Year Chg |
7.3% |
(6.1%) |
1.0% |
| Financials |
SBC |
Industry Median |
Percentile (All Stocks) |
| Sales (TTM) (Mil) |
$169 |
$1,456 |
31% |
|
| Net Income (TTM) (Mil) |
$41 |
$12 |
54% |
|
| EPS (TTM) |
$0.397 |
$0.300 |
51% |
|
| Operating Cash Flow (TTM) (Mil) |
$32 |
$138 |
44% |
|
| Net Cash Flow (TTM) (Mil) |
$35 |
$8 |
67% |
|
| Long-Term Debt (Q1) (Mil) |
$37 |
$316 |
37% |
|
| Enterprise Value (Q1) (Mil) |
$207 |
$2,170 |
26% |
|
| Valuation |
SBC |
Industry Median |
Percentile (All Stocks) |
| P/B |
1.23 |
2.85 |
31% |
|
| P/E |
7.7 |
26.7 |
9% |
|
| Dividend Yield |
0.0% |
0.0% |
0% |
|
| PEG (5yr hist) |
na |
1.1 |
na |
|
| Ratios |
SBC |
Industry Median |
Percentile (All Stocks) |
| Gross Margin |
70.8% |
27.8% |
82% |
|
| Net Margin |
24.1% |
1.1% |
83% |
|
| ROA |
12.1% |
1.8% |
90% |
|
| ROE |
16.9% |
7.1% |
75% |
|
| Liabilities to Assets |
30.3% |
59.9% |
21% |
|
| F-Score |
3 |
5 |
19% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
SBC meetings the criteria of 1 screen:
Stock Screen
GURU STRATEGY
Magic Formula Screen
Factors: Value, Quality
Joel Greenblatt's investing approach is based on finding companies with high return on investment that are trading for less than they are worth.